News
Pharmaceutical Technology on MSN1d
Roche extends SMA market lead with Evrysdi tablet approval in EuropeAlready offering the only non-invasive treatment for SMA in liquid form, Roche’s Evrysdi now comes as a tablet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback